[Progress in disc degeneration models and calcitonin therapy]

Area of Science:

• Biomedical research
• Orthopedics
• Regenerative medicine

Background:

• Intervertebral disc degeneration (IDD) is a major cause of low back pain.
• Current treatment options for IDD are limited and often focus on symptom management.
• Understanding IDD mechanisms and exploring novel therapeutic agents are crucial.

Purpose of the Study:

• To review existing models for studying disc degeneration.
• To summarize the current therapeutic status of calcitonin for disc degeneration.

Main Methods:

• Comprehensive literature search on disc degeneration models.
• Systematic review of studies investigating calcitonin's efficacy in disc degeneration.

Main Results:

• Various disc degeneration models possess distinct advantages and limitations.
• Calcitonin demonstrated efficacy in mitigating disc degeneration in both in vitro and in vivo experimental settings.
• The degree of relief provided by calcitonin varied across different studies.

Conclusions:

• Disc degeneration models provide valuable insights into disease mechanisms.
• The findings on calcitonin's therapeutic effects in experimental models serve as a foundation for future clinical investigations.
• Further research is warranted to elucidate calcitonin's precise role in treating human disc degeneration.